An ADHD rating scale is a tool used for reporting attention-deficit/hyperactivity disorder (ADHD) symptoms during the diagnostic process. There are numerous scales ...
"Our results provide further support for the validity of diagnoses of ADHD that are made in adulthood as these adults show a profile of clinical features that is very similar to those seen in adults ...
Clinical Trials Arena on MSN
Otsuka’s ADHD drug reduces symptoms in Phase IIIb trial
Otsuka’s ADHD drug centanafadine is currently under review by the US FDA, with a PDUFA date of 24 July 2026.
Agave Health announces the deployment of the Unified Protocol across its clinical care model, strengthening its structured approach to treating adult ADHD. Deploying the Unified Protocol allows Agave ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results